Richard K. Yang

1.9k total citations
52 papers, 1.4k citations indexed

About

Richard K. Yang is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Richard K. Yang has authored 52 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 16 papers in Immunology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Richard K. Yang's work include Cancer Genomics and Diagnostics (8 papers), Cutaneous Melanoma Detection and Management (7 papers) and Immunotherapy and Immune Responses (6 papers). Richard K. Yang is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Cutaneous Melanoma Detection and Management (7 papers) and Immunotherapy and Immune Responses (6 papers). Richard K. Yang collaborates with scholars based in United States, United Kingdom and Italy. Richard K. Yang's co-authors include Marilyn S. Smith, David W. Graham, Charles W. Knapp, Diana S. Aga, Paul M. Sondel, Jacquelyn A. Hank, Stephen D. Gillies, John A. Hey, Charles A. Rizzo and Paul M. Sondel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Richard K. Yang

48 papers receiving 1.3k citations

Peers

Countries citing papers authored by Richard K. Yang

Since Specialization

Citations

This map shows the geographic impact of Richard K. Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard K. Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard K. Yang more than expected).

Fields of papers citing papers by Richard K. Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard K. Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard K. Yang. The network helps show where Richard K. Yang may publish in the future.

Co-authorship network of co-authors of Richard K. Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Richard K. Yang. A scholar is included among the top collaborators of Richard K. Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard K. Yang. Richard K. Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Routine Clinical Liquid Biopsy Testing for Solid Tumors Delivers the Promise of Minimally Invasive Detection of Genomic Variants With a Faster Turnaround Time 2025 ·JCO Precision Oncology ·(unknown), Richard K. Yang, Fatima Zahra Jelloul, Rajyalakshmi Luthra, Mark J. Routbort, Hui Chen, Sanam Loghavi, Chi Young Ok, Rashmi Kanagal‐Shamanna, Sinchita Roy‐Chowdhuri, L. Jeffrey Medeiros, Keyur P. Patel	2
2	Melanoma With RNF11::BRAF Fusion: A Novel Fusion Previously Undescribed in Melanoma 2025 ·American Journal of Dermatopathology ·Yan Gao, Richard K. Yang, Jonathan L. Curry, Carlos A. Torres‐Cabala, Woo Cheal Cho	2
3	NSD3::FGFR1: A Novel Gene Fusion First to Be Described in Merkel Cell Carcinoma 2025 ·American Journal of Dermatopathology ·(unknown), Richard K. Yang, Phyu P. Aung, Víctor G. Prieto, Priyadharsini Nagarajan, Woo Cheal Cho	2
4	Patterns of toxic side effects and prognostic factors in concurrent chemoradiotherapy for esophageal cancer 2025 ·Diseases of the Esophagus ·(unknown), (unknown), Bo Cui, Lijun Wang, Yulin Liao, Yanli Li, Xiaolin Zhu, Yuanyuan Zhang, (unknown), Sujun Gao, Richard K. Yang, (unknown)	0
5	Fatal Melanoma With MAP4::RAF1 Fusion: Expanding the Clinicopathologic and Prognostic Spectrum of RAF1-Fused Melanomas 2025 ·American Journal of Dermatopathology ·(unknown), Richard K. Yang, Jonathan L. Curry, Woo Cheal Cho	0
6	Long-Term Follow-up of Levonorgestrel Intrauterine Device for Atypical Hyperplasia and Early Endometrial Cancer Reveals Relapse Characterized by Immune Exhaustion 2024 ·Clinical Cancer Research ·(unknown), Brenda Melendez, Qian Zhang, Richard K. Yang, Bryan Fellman, (unknown), (unknown), Joseph Celestino, Khalida Wani, (unknown), Diana L. Urbauer, Alexander J. Lazar, Karen H. Lu, Jennifer A. Wargo, Shannon N. Westin, Melinda S. Yates	1
7	KAT2A and KAT2B prevent double-stranded RNA accumulation and interferon signaling to maintain intestinal stem cell renewal 2024 ·Science Advances ·(unknown), Jahangir Iqbal, (unknown), (unknown), J M Pfeffer, (unknown), Caifeng Zhao, Matthew A. Lawlor, Richard K. Yang, (unknown), (unknown), Sharon Dent, José B. Sáenz, Haiyan Zheng, Zuo‐Fei Yuan, Simone Sidoli, Christopher E. Ellison, Michael P. Verzi	4
8	Müllerian-Type Clear Cell Carcinoma of Donor Origin in a Male Patient with a Kidney Transplant: Ascertained by Molecular Testing 2023 ·Current Oncology ·J. Bryan Iorgulescu, (unknown), Asif Rashid, Priya Rao, Sreedhar Mandayam, Keyur P. Patel, Kathleen M. Schmeler, Richard K. Yang, Pavlos Msaouel	1
9	Recurrent Somatic Copy Number Alterations and Their Association with Oncogene Expression Levels in High-Grade Ovarian Serous Carcinoma 2023 ·Life ·(unknown), Richard K. Yang, Awdhesh Kalia, Zhenya Tang, Guilin Tang, L. Jeffrey Medeiros, Gökçe Törüner	3
10	Clinicopathologic Features of Therapy-Related Myeloid Neoplasms in Patients with Myeloma in the Era of Novel Therapies 2023 ·Modern Pathology ·Fatima Zahra Jelloul, Andres Quesada, Richard K. Yang, Shaoying Li, Wei Wang, Jie Xu, Guilin Tang, C. Cameron Yin, Hong Fang, Siba El Hussein, Joseph D. Khoury, Roland L. Bassett, Guillermo Garcia‐Manero, (unknown), Robert Z. Orlowski, Muzaffar H. Qazilbash, Keyur P. Patel, L. Jeffrey Medeiros, Pei Lin	5
11	TP53 variant allele frequency correlates with the chemotherapy response score in ovarian/fallopian tube/peritoneal high-grade serous carcinoma 2021 ·Human Pathology ·(unknown), Richard K. Yang, Elizabeth D. Euscher, Preetha Ramalingam, Anaís Malpica	2
12	Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2 2020 ·Clinical Cancer Research ·Richard K. Yang, Igor B. Kuznetsov, Erik A. Ranheim, Jun S. Wei, Sivasish Sindiri, Berkley E. Gryder, Vineela Gangalapudi, Young Song, (unknown), Jacquelyn A. Hank, Cindy Zuleger, Amy K. Erbe, Zachary S. Morris, (unknown), KyungMann Kim, Mark R. Albertini, (unknown), Paul M. Sondel	17
13	Endometrial biomarkers in premenopausal women with obesity: an at-risk cohort 2020 ·American Journal of Obstetrics and Gynecology ·Joseph Dottino, Qian Zhang, David S. Loose, Bryan Fellman, Brenda Melendez, (unknown), Laurie J. McKenzie, Ying Yuan, Richard K. Yang, Russell R. Broaddus, Karen H. Lu, Pamela T. Soliman, Melinda S. Yates	7
14	Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies 2020 ·Current Hematologic Malignancy Reports ·Arash Ronaghy, Richard K. Yang, Joseph D. Khoury, Rashmi Kanagal‐Shamanna	7
15	Expression pattern of androgen receptor and AR-V7 in androgen-deprivation therapy–naïve salivary duct carcinomas 2018 ·Human Pathology ·Richard K. Yang, Pei Zhao, Changxue Lu, Jun Luo, Rong Hu	16
16	In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments 2016 ·Cancer Research ·Zachary S. Morris, (unknown), David M. Francis, (unknown), Lauryn R. Werner, Lakeesha Carmichael, Richard K. Yang, Eric A. Armstrong, Shyhmin Huang, Fariba Navid, Stephen D. Gillies, Alan J. Korman, Jacquelyn A. Hank, Alexander L. Rakhmilevich, Paul M. Harari, Paul M. Sondel	119
17	Tumor-associated myeloid cells can be activated in vitro and in vivo to mediate antitumor effects 2012 ·Cancer Immunology Immunotherapy ·Alexander L. Rakhmilevich, (unknown), (unknown), Mildred Felder, Richard K. Yang, Nicholas A. Kalogriopoulos, (unknown), Nico van Rooijen, Paul M. Sondel	12
18	Soluble interleukin‐2 receptor α activation in a Children's Oncology Group randomized trial of interleukin‐2 Therapy for Pediatric Acute Myeloid Leukemia 2011 ·Pediatric Blood & Cancer ·Beverly J. Lange, Richard K. Yang, Jacek Gan, (unknown), Eric L. Sievers, Todd A. Alonzo, Robert B. Gerbing, Paul M. Sondel	7
19	Correlations between in situ denitrification activity and nir-gene abundances in pristine and impacted prairie streams 2010 ·Environmental Pollution ·David W. Graham, (unknown), Walter K. Dodds, Jonathan M. O’Brien, (unknown), Ian M. Head, Marilyn S. Smith, Richard K. Yang, Charles W. Knapp	77
20	The IL-5 receptor on human bronchus selectively primes for hyperresponsiveness 2002 ·Journal of Allergy and Clinical Immunology ·Charles A. Rizzo, Richard K. Yang, Scott Greenfeder, Robert W. Egan, Romain Pauwels, John A. Hey	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact